A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Parecoxib Impurity 20 | CAS 37928-17-9 - Request Quote

Picture of Parecoxib Impurity 20

Parecoxib Impurity 20

SZ CAT No:SZ-P047025
CAS No
37928-17-9
Mol.F.
C16H13NO 
Mol.Wt.
235.3
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Parecoxib Impurity 20 is chemically 5-methyl-3,4-diphenylisoxazole. Parecoxib Impurity 20 is supplied with detailed characterization data compliant with regulatory guideline. Parecoxib Impurity 20 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Parecoxib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 37928-17-9

Purchase 37928-17-9

Order 37928-17-9

Enquire 37928-17-9

price of 37928-17-9

37928-17-9 Supplier

37928-17-9 Manufacturer

37928-17-9 Exporter

buy high quality Parecoxib Impurity 20

Purchase Parecoxib Impurity 20

Parecoxib Impurity 20 suppliers

Parecoxib Impurity 20 manufacturers

Parecoxib Impurity 20 price

Order Parecoxib Impurity 20

Enquire Parecoxib Impurity 20

Parecoxib Impurity 20 cost

Parecoxib Impurity 20 Supplier

Parecoxib Impurity 20 Distributor

Parecoxib Impurity 20 for Method Validation

Parecoxib Reference Standard

Parecoxib Impurity 20 for ANDA Filing

Parecoxib Impurity 20 for Forced Degradation Studies

Parecoxib Impurity 20 Identification Standards

Parecoxib Impurity 20 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,